Faculty

Institution

Unit

Venue

Nabil M Ahmed

Professor

Baylor College of Medicine

Affiliations

Baylor College of Medicine Research

Nabil M Ahmed is currently serving as a Baylor College Of Medicine Research Professor at Baylor College of Medicine.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Nabil M Ahmed

Baylor College of Medicine

Professor

You can click a keyword to filter the displayed items

immunology cancer immunotherapy cellular therapy immunotherapy cancer cells brain tumor research cell biology cell transplantation gliomas oncology neuro-oncology tumor biology cellular immune responses immune responses cell therapy cancer research medicine oncogenes cancer immunosurveillance medicinal research cancer biology bone marrow transplantation cancer treatment tumor targeting molecular cancer transplantation medicine stem cell transplantation adaptive immune system immune checkpoint inhibitors pediatric transplantation immunoediting cancer discovery clinical transplantation neuroscience t-regulatory cell pediatric hematology hematological malignancies leukemia cancer care novel therapies clinical immunology vascular biology stem cell research medical virology lymphoid neoplasia tumor suppressors therapeutic vaccines pediatric patients tumoral pathology progressive glioblastoma brain-immune interaction cancer genomics adoptive immunotherapy molecular immunology viral oncology interpatient antigenic variability triple-negative breast cancer advanced sarcoma brain cancer immunomodulation immunopathology lymphocyte development blood transfusion cerebrospinal fluid stem-cell therapy locoregional delivery genetic modification author correction solid tumors autologous experimental tumors cytokines inflammatory markers current concepts cytokine release syndrome malignant analogs diverse astrocyte populations gene therapy

Notable Scholarly Works

Notable Federal Grants

Collaborators

A Checkpoint Reversal Receptor Mediates Bipartite Activation and Enhances Car T-Cell Function. Cancer Research Communications (2025)

Daniel LandiShoba A. NavaiRebecca M. BrockKristen FousekZeid NawasKhaled SanberCynthia Chauvin-FleurenceRaksha R. BhatShuo XuPurna KrishnamurthyMichelle ChoeMatthew CampbellJessica S. MorrisAhmed Z. GadAnkita ShreeAlesandra EcheandiaAmr SaadeldinPretty R. MatthewDolores MullikinKevin BielamowiczLyazat KurenbekovaAngela M. MajorVita S. SalsmanTiara T. ByrdM. John HicksYi Jonathan. ZhangJason YusteinAlexandre F. CariseySujith K. JosephNabil AhmedMeenakshi Hegde

immunologyreceptorscancer researchsystems biologyimmune checkpoint inhibitorscancer immunotherapymolecular biologyoncologyimmune responsest-regulatory cellcancer treatmentbipartite activationcancer biologycheckpoint reversal receptor

Cardiovascular Complications of Immune Effector Cell Therapies in Pediatric Hematological and Solid Tumors. Pediatric Blood & Cancer (2025)

Aaron B. RossKriti PuriThomas L. JohnsonLilliam D. CorreaTami D. JohnBrian FriendShoba A. NavaiNabil AhmedMeenakshi G. HegdeBilal OmerAndras HeczeyBaheyeldin M. SalemHossein TcharmtchiRayne H. RouceDavid H. SteffinRobert A KranceNino C. RainussoSaleh Bhar

cardiovascular complicationssolid tumorshematologypediatric hematologypediatric heart diseasepediatrics

Molecular Dynamics at Immune Synapse Lipid Rafts Influence the Cytolytic Behavior of Car T Cells. Science Advances (2025)

Ahmed Z. GadJessica S. MorrisLea Godret-MiertschinMelisa J. MontalvoSybrina S. KerrHarrison BergerJessica C. H. LeeAmr M. SaadeldinMohammad H. Abu-ArjaShuo XuSpyridoula VasileiouRebecca M. BrockKristen FousekMohamed F. ShehaMadhuwanti SrinivasanYongshuai LiArash SaeediKandice R. LeventalAnn M. LeenMaksim MamonkinAlexandre CariseyNavin VaradarajanMeenakshi HegdeSujith K. JosephIlya LeventalMalini MukherjeeNabil Ahmed

immunologysystems biologymolecular dynamicsscience advancemolecular immunologymolecular biologycytolytic behaviorimmune responses

Supplementary Figure 7 From a Checkpoint Reversal Receptor Mediates Bipartite Activation and Enhances Car T-Cell Function. (2025)

Daniel LandiShoba A. NavaiRebecca M. BrockKristen FousekZeid NawasKhaled SanberCynthia Chauvin-FleurenceRaksha R. BhatShuo XuPurna KrishnamurthyMichelle ChoeMatthew E. CampbellJessica S. MorrisAhmed Z. GadAnkita ShreeAlesandra S. Echeandia MarreroAmr M. SaadeldinPretty R. MatthewDolores MullikinKevin BielamowiczLyazat KurenbekovaAngela M. MajorVita S. SalsmanTiara T. ByrdJohn M. HicksYi Jonathan ZhangJason YusteinAlexandre F. CariseySujith K. JosephNabil AhmedMeenakshi Hegde

immunologyreceptorsmolecular biologyt-regulatory cellimmune responsesbipartite activationcheckpoint reversal receptor

ZP4: A Novel Target for Car T Cell Therapy in Triple Negative Breast Cancer. Molecular Therapy (2025)

Lauren K SomesJonathan T LeiXinpei YiDiego F ChamorroPaul ShaferAhmed Z GadLacey E DobroleckiEmily MadarasNabil AhmedMichael T LewisBing ZhangValentina Hoyos

immunologycell therapycellular immune responsescancer researchmolecular cancernovel therapiescancer discoverytherapeutic targetscancer immunotherapybreast cancermolecular biologyoncologycancer cellscancer treatmentt-regulatory cellnovel targetcellular therapycell biology

263 a Chemically Tunable Molecular Rheostat for Control of Her2 Car T Cell Activity. Regular and Young Investigator Award Abstracts (2024)

tunable molecular rheostatbiophysical chemistrychemical biologybiomolecular engineeringmolecular biologybiochemical sciencesbiochemistry

Author Correction: Identification of a Clinically Efficacious Car T Cell Subset in Diffuse Large B Cell Lymphoma by Dynamic Multidimensional Single-Cell Profiling. Nature Cancer (2024)

Ali RezvanGabrielle RomainMohsen FathiDarren HeekeMelisa Martinez-PaniaguaXingyue AnIrfan N. BandeyMelisa J. MontalvoJay R. T. AdolacionArash SaeediFatemeh SadeghiKristen FousekNahum Puebla-OsorioLaurence J. N. CooperChantale BernatchezHarjeet SinghNabil AhmedMike MattieAdrian BotSattva NeelapuNavin Varadarajan

cancer carehematologycancer genomicscancer biologydermatologycancer researchsingle-cell analysislymphoid neoplasiacancer immunotherapyauthor correctionimmunotherapyimmunologypharmacologyclinical immunologycancer imagingoncologymedicinal researchcellular therapyexperimental medicine

Autologous Her2-Specific Car T Cells After Lymphodepletion for Advanced Sarcoma: A Phase 1 Trial. Nature Cancer (2024)

Meenakshi HegdeShoba NavaiChristopher DeRenzoSujith K. JosephKhaled SanberMengfen WuAhmed Z. GadKatherine A. JanewayMatthew CampbellDolores MullikinZeid NawasCatherine RobertsonPretty R. MathewHuimin ZhangBirju MehtaRaksha R. BhatAngela MajorAnkita ShreeClaudia GerkenMamta KalraRikhia ChakrabortySachin G. ThakkarOlga DakhovaVita S. SalsmanBambi GrilleyNatalia LaptevaAdrian GeeGianpietro DottiRiyue BaoAhmed Hamed SalemTao WangMalcolm K. BrennerHelen E. HeslopWinfried S. WelsM. John HicksStephen GottschalkNabil Ahmed

cellular immune responsescell biologymedicinecancer careadaptive immune systemcancer biologycell therapycancer researchcancer immunotherapysarcomaadvanced sarcomatumor biologyimmunologyclinical immunologyoncologycell transplantationmedicinal researchcancer cellscellular therapy

Cnsc-12. Immunologically Targeting U1 Mutant Shh Medulloblastoma. Neuro-Oncology (2024)

immunologymolecular cancercancer immunosurveillancemalignant diseasecancer immunotherapyoncogenescancer cellspathologytumor biologyimmunotherapy

Early Rhombic Lip Protogenin+Ve Stem Cells in a Human-Specific Neurovascular Niche Initiate and Maintain Group 3 Medulloblastoma. Cell (2024)

Abhirami VisvanathanOlivier SaulnierChuan ChenParthiv HaldipurWilda OrismeAlberto DelaidelliSeungmin ShinJake MillmanAndrew BryantNamal AbeysundaraXujia WuLiam D. HendrikseVikas PatilZahedeh BashardaneshJoseph GolserBryn G. LivingstonTakuma NakashimaYusuke FunakoshiWinnie OngAlexandra RasnitsynKimberly A. AldingerCory M. RichmanRandy Van OmmerenJohn J.Y. LeeMichelle LyMaria C. VladoiuKaitlin KharasPolina BalinAnders W. EricksonVernon FongJiao ZhangRaúl A. SuárezHao WangNing HuangJonelle G. PallotaTajana DouglasJoonas HaapasaloFerechte RazaviEvelina SilvestriOlga SirbuSamantha WormeMichelle M. Kameda-SmithXiaochong WuCraig DanielsAntony K. MichaelRajAparna BhaduriDaniel SchramekHiromichi SuzukiLivia GarziaNabil AhmedClaudia L. KleinmanLincoln D. SteinPeter DirksChristopher DunhamNada JabadoJeremy N. RichWei LiPoul H. SorensenRobert J. Wechsler-ReyaWilliam A. WeissKathleen J. MillenDavid W. EllisonDimiter S. DimitrovMichael D. Taylor

neurologyangiogenesisstem cell researchgliomascellular biologyregenerative medicinebrain tumor researchvascular biologycellular therapycancer growthstem-cell therapystem cellsneuro-oncologymedicinal researchtumor biologyneurosciencecell biology

1
2
3
4
5
31
10 / page

Nabil M Ahmed

Professor

Baylor College of Medicine

Affiliations

Baylor College of Medicine Research

Nabil M Ahmed is currently serving as a Baylor College Of Medicine Research Professor at Baylor College of Medicine.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Nabil M Ahmed

Baylor College of Medicine

Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

A Checkpoint Reversal Receptor Mediates Bipartite Activation and Enhances Car T-Cell Function. Cancer Research Communications (2025)

Cardiovascular Complications of Immune Effector Cell Therapies in Pediatric Hematological and Solid Tumors. Pediatric Blood & Cancer (2025)

cardiovascular complicationssolid tumorshematologypediatric hematologypediatric heart diseasepediatrics

Molecular Dynamics at Immune Synapse Lipid Rafts Influence the Cytolytic Behavior of Car T Cells. Science Advances (2025)

immunologysystems biologymolecular dynamicsscience advancemolecular immunologymolecular biologycytolytic behaviorimmune responses

Supplementary Figure 7 From a Checkpoint Reversal Receptor Mediates Bipartite Activation and Enhances Car T-Cell Function. (2025)

Daniel LandiShoba A. NavaiRebecca M. BrockKristen FousekZeid NawasKhaled SanberCynthia Chauvin-FleurenceRaksha R. BhatShuo XuPurna KrishnamurthyMichelle ChoeMatthew E. CampbellJessica S. MorrisAhmed Z. GadAnkita ShreeAlesandra S. Echeandia MarreroAmr M. SaadeldinPretty R. MatthewDolores MullikinKevin BielamowiczLyazat KurenbekovaAngela M. MajorVita S. SalsmanTiara T. ByrdJohn M. HicksYi Jonathan ZhangJason YusteinAlexandre F. CariseySujith K. JosephNabil AhmedMeenakshi Hegde

immunologyreceptorsmolecular biologyt-regulatory cellimmune responsesbipartite activationcheckpoint reversal receptor

ZP4: A Novel Target for Car T Cell Therapy in Triple Negative Breast Cancer. Molecular Therapy (2025)

Lauren K SomesJonathan T LeiXinpei YiDiego F ChamorroPaul ShaferAhmed Z GadLacey E DobroleckiEmily MadarasNabil AhmedMichael T LewisBing ZhangValentina Hoyos

263 a Chemically Tunable Molecular Rheostat for Control of Her2 Car T Cell Activity. Regular and Young Investigator Award Abstracts (2024)

tunable molecular rheostatbiophysical chemistrychemical biologybiomolecular engineeringmolecular biologybiochemical sciencesbiochemistry

Author Correction: Identification of a Clinically Efficacious Car T Cell Subset in Diffuse Large B Cell Lymphoma by Dynamic Multidimensional Single-Cell Profiling. Nature Cancer (2024)

Autologous Her2-Specific Car T Cells After Lymphodepletion for Advanced Sarcoma: A Phase 1 Trial. Nature Cancer (2024)

Cnsc-12. Immunologically Targeting U1 Mutant Shh Medulloblastoma. Neuro-Oncology (2024)

immunologymolecular cancercancer immunosurveillancemalignant diseasecancer immunotherapyoncogenescancer cellspathologytumor biologyimmunotherapy

Early Rhombic Lip Protogenin+Ve Stem Cells in a Human-Specific Neurovascular Niche Initiate and Maintain Group 3 Medulloblastoma. Cell (2024)

1
2
3
4
5
31
10 / page

Similar Faculty Members

Ann Marie Leen

Institution

Baylor College of Medicine

cellular therapy

immunology

Stephen Gottschalk, MD

Institution

Baylor College of Medicine

cellular therapy

immunology

Bryon D. Johnson

Institution

Medical College of Wisconsin

cellular therapy

immune response

Cliona Rooney

Institution

Baylor College of Medicine

pediatric cancer

immunology

Walter J. Storkus

Institution

University of Pittsburgh

immunomodulation

tumor immunobiology

Malcolm Brenner

Institution

Baylor College of Medicine

cellular therapy

radiation oncology

Lawrence Lum

Institution

University of Virginia

immunology

cell transplantation

Barbara Savoldo

Institution

University of North Carolina at Chapel Hill

cancer letter

clinical infectious disease

Theresa L. Whiteside

Institution

University of Pittsburgh

t-regulatory cell

pathology

stephen tomlinson

Institution

Medical University of South Carolina

clinical transplantation

immune mediator

Similar Faculty Members

Ann Marie Leen

Institution

Baylor College of Medicine

cellular therapy

immunology

Stephen Gottschalk, MD

Institution

Baylor College of Medicine

cellular therapy

immunology

Bryon D. Johnson

Institution

Medical College of Wisconsin

cellular therapy

immune response

Cliona Rooney

Institution

Baylor College of Medicine

pediatric cancer

immunology

Walter J. Storkus

Institution

University of Pittsburgh

immunomodulation

tumor immunobiology

Malcolm Brenner

Institution

Baylor College of Medicine

cellular therapy

radiation oncology

Lawrence Lum

Institution

University of Virginia

immunology

cell transplantation

Barbara Savoldo

Institution

University of North Carolina at Chapel Hill

cancer letter

clinical infectious disease

Theresa L. Whiteside

Institution

University of Pittsburgh

t-regulatory cell

pathology

stephen tomlinson

Institution

Medical University of South Carolina

clinical transplantation

immune mediator